What is HeartFlow?
HeartFlow is at the forefront of medical innovation, developing advanced technologies to address coronary artery disease. The company's unique approach combines extensive human ingenuity with cutting-edge technology, aiming to provide novel solutions for diagnosis and patient management. Their commitment to pushing boundaries and forging strategic partnerships positions them as a leader in the cardiovascular health sector.
How much funding has HeartFlow raised?
HeartFlow has raised a total of $890.7M across 11 funding rounds:
Series C
$104.7M
Unspecified
$35.9M
Series D
$99.9M
Series E
$240M
Unspecified
$65M
Series F
$215M
Other Financing Round
$98M
Series C (2014): $104.7M backed by Capricorn Investment Group, LLC, Orkila Capital, LLC, U.S. Venture Partners, HealthCor Partners Management, and Sandbox Industries Inc.
Unspecified (2015): $35.9M with participation from Capricorn Investment Group and U.S. Venture Partners
Series D (2016): $99.9M led by Panorama Point Partners
Series E (2018): $240M supported by Baillie Gifford, U.S. Venture Partners, Rancilio Cube srl, Blue Cross Blue Shield, GE Ventures, and Wellington Management
Unspecified (2019): $65M, investors not publicly disclosed
Series F (2023): $215M backed by Wellington Management, Bain Capital Life Sciences, Janus Henderson Group, Baillie Gifford, Hayfin, USVP Management, Capricorn Investment Group, Martis Capital, and HealthCor Partners Management
Other Financing Round (2025): $98M with participation from Martis Capital, Hayfin, Fidelity, Bain Capital, Capricorn Group, HealthCor Partners Management, and US Venture Partners
Key Investors in HeartFlow
Capricorn Investment Group
Capricorn Investment Group is a Palo Alto-based investment firm that manages diversified portfolios for mission-aligned families, foundations, and institutional investors, with a strong focus on sustainable, climate, and impact investments.
U.S. Venture Partners
U.S. Venture Partners (USVP) is a prominent Silicon Valley venture capital firm dedicated to collaborating with entrepreneurs to develop transformative companies, specializing in early-stage investments across sectors like cybersecurity, enterprise software, consumer products, and healthcare.
Baillie Gifford
Baillie Gifford is an investment management firm founded in Edinburgh in 1908, specializing in giving investment advice and managing diverse portfolios.
What's next for HeartFlow?
With the infusion of major enterprise-level funding and a recent strategic investment, HeartFlow is poised for accelerated growth and further innovation. This capital infusion will likely support the expansion of its technological capabilities, market penetration, and the development of new frontiers in precision heart care. The company's trajectory suggests a continued focus on enhancing diagnostic accuracy and treatment strategies for cardiovascular conditions, solidifying its position as a key player in the medtech industry.
See full HeartFlow company page
